Cardio Diagnostics Holdings, Inc.
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc.
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
Cardio Diagnostics Holdings, Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
Cardio Diagnostics Holdings, Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of Cardio Diagnostics Holdings, Inc..